The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for further batches of Ozurdex 700 micrograms intravitreal implant in applicator (dexamethasone) due to t
Gabapentin and pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs). This means from 1 April 2019:
Prescriptions for gabapentin and pregabalin need to meet full prescription require
An interim funding agreement has been agreed in advance of the start of actual negotiations on future pharmacy funding.
The Department of Health and Social Care and PSNC have agreed community pharmac
The MHRA has released a Medical Device Alert (MDA) for the enFlow IV fluid and blood warmer (manufactured by Vyaire)…
Accord Healthcare Limited has informed MHRA there is an error …